• a National Institute of Clinical Excellence to promote clinical and cost effectiveness by producing clinical guidelines and audits for dissemination throughout the NHS;
• a Commission for Health Improvement to support and oversee the quality of clinical governance and of clinical services.
Several comments can be made. Firstly, experience already exists in Britain and in other countries, such as America and the Netherlands, in quality assurance and the production of guidelines. The National Institute of Clinical Excellence could profit from these experiences, notably about the processes which work or do not work. However, it is the lessons about approaches that are transferable, not necessarily the guidelines themselves.
Secondly, the prospective users of the guidelines should be involved in preparing them (using an explicit and systematic approach) and potential barriers for implementation should be identified. Last October, the second international conference on the scientific basis of health services in Amsterdam clearly showed that leading clinicians and scientists support guideline development, although it is not easy to make guidelines that will actually be used in practice. The best basis for guidelines is systematic reviews of primary research, as prepared by the Cochrane Collaboration, the NHS Centre for Reviews and Dissemination, and others.
Commissioning of systematic reviews should be carefully coordinated, and such reviews should ideally deal with cross cultural differences and cost effectiveness.
Good coordination is needed between the many groups engaged in doing the reviews and overseeing their implementation, to prevent duplication of effort and waste of money-not an easy task. Recently, programmes in the Netherlands and Denmark have been started in which the different parties engaged in preparing reviews, developing guidelines, analysing cost effectiveness, and performing dissemination and implementation research work together.
Thirdly, explicit attention should be paid to the values and judgments underlying specific guidelines. These values reflect the value structure of the teams developing the guidelines but may be different across countries. Differences in practitioners' barriers, patients' barriers, and cost barriers may also restrict generalisability, especially when it comes to implementation. Guidelines developed in different countries on the same topic are often different and may not always be interchangeable. Guideline development, dissemination, and implementation can thus be improved.
However, it may be a challenge for the Commission for Health Improvement, as top down organisation, to assess and really influence daily practice in the NHS:
improvements can only really be made by those engaged in providing the services.
